English
全部
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
生物通
15 天
Vertex 非阿片镇痛药获批,开启 NaV1.8 靶点疼痛治疗新时代
社会各界、患者和临床医生对这种急需的非阿片类止痛药表示欢迎。Vertex 公司的一流镇痛药 Journavx(舒泽曲吉)获批后,新一代作用于 NaV1.8 钠通道且无成瘾性的止痛药可能即将问世。
腾讯网
15 天
数十年来首款非阿片类止痛药,Suzetrigine获美国FDA批准
Suzetrigine是创新性的非阿片类口服药物,作为口服电压门控钠(NaV)通道抑制剂,可选择性抑制NaV1.8痛觉信号,用于治疗中度至重度急性疼痛。
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Retaliate against US tariffs
US halts military aid to UKR
Day care owner sentenced
Panama Canal ports deal
Tops list of biggest donors
Houthis get terrorist label
Wins 2025 Pritzker Prize
Launches new iPad Air
Chappy the baby seal dies
Kids sickened by marijuana
Texas measles cases rise
NK leader's sister warns US
Obesity rates rise globally
Prepare to return
Probe into case closed?
Recall over faulty LED lights
Says he may run for pres
CFPB drops 'Zelle' case
Trump clash 'regrettable'
Judge reinstates fired chair
Fort Moore’s name changed
May help trigger quakes?
4 men federally charged
Winter storm warning
Trailblazing lawmaker dies
2025 NFL mock draft
Conviction under DOJ review
Serbian lawmakers injured
Austin robotaxi launch
Limits water discharge rules
Largest iceberg runs aground
Off mechanical ventilation
Intentionally set on fire?
反馈